120 related articles for article (PubMed ID: 3019531)
1. Predominant role for DNA damage in etoposide-induced cytotoxicity and cell cycle perturbation in human SV40-transformed fibroblasts.
Smith PJ; Anderson CO; Watson JV
Cancer Res; 1986 Nov; 46(11):5641-5. PubMed ID: 3019531
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.
Epstein RJ; Smith PJ
Cancer Res; 1988 Jan; 48(2):297-303. PubMed ID: 2825970
[TBL] [Abstract][Full Text] [Related]
3. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide.
Giocanti N; Hennequin C; Balosso J; Mahler M; Favaudon V
Cancer Res; 1993 May; 53(9):2105-11. PubMed ID: 8386982
[TBL] [Abstract][Full Text] [Related]
4. DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action.
Sinha BK; Haim N; Dusre L; Kerrigan D; Pommier Y
Cancer Res; 1988 Sep; 48(18):5096-100. PubMed ID: 2842045
[TBL] [Abstract][Full Text] [Related]
5. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
[TBL] [Abstract][Full Text] [Related]
7. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity of cultured ataxia-telangiectasia cells to etoposide.
Henner WD; Blazka ME
J Natl Cancer Inst; 1986 Jun; 76(6):1007-11. PubMed ID: 2423735
[TBL] [Abstract][Full Text] [Related]
9. Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line.
Smith PJ; Makinson TA
Cancer Res; 1989 Mar; 49(5):1118-24. PubMed ID: 2537142
[TBL] [Abstract][Full Text] [Related]
10. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Yalowich JC; Ross WE
Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
[TBL] [Abstract][Full Text] [Related]
11. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
Yalowich JC
Cancer Res; 1987 Feb; 47(4):1010-5. PubMed ID: 2879622
[TBL] [Abstract][Full Text] [Related]
12. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE
Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
[TBL] [Abstract][Full Text] [Related]
13. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts.
Kalwinsky DK; Look AT; Ducore J; Fridland A
Cancer Res; 1983 Apr; 43(4):1592-7. PubMed ID: 6572554
[TBL] [Abstract][Full Text] [Related]
14. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
15. Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells.
Pandita TK; Hittelman WN
Radiat Res; 1992 Apr; 130(1):94-103. PubMed ID: 1561323
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
[TBL] [Abstract][Full Text] [Related]
17. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Catchpoole DR; Stewart BW
Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
Mirzayans R; Smith BP; Paterson MC
Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
[TBL] [Abstract][Full Text] [Related]
19. Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage.
Schonn I; Hennesen J; Dartsch DC
Apoptosis; 2010 Feb; 15(2):162-72. PubMed ID: 20041303
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16).
Tronov VA; Konoplyannikov MA; Nikolskaya TA; Konstantinov EM
Biochemistry (Mosc); 1999 Mar; 64(3):345-52. PubMed ID: 10205305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
